Detection of Right Ventricular Dysfunction by 2D Strain During Acute Respiratory Distress Syndrom (ARDS)
STRAIN
1 other identifier
observational
47
1 country
1
Brief Summary
Acute respiratory distress syndrome (ARDS) and mechanical ventilation can lead to right ventricular dysfunction and ultimately right ventricular failure by increasing pulmonary vascular resistances and pressure load. This can be prevented by modifying ventilator settings, using vasopressors or inotropes or even by prone positionning.But to do so, right ventricular dysfonction has to be detected. Echocardiography has emerged as a first line tool to diagnose right heart failure. Recently, strain analysis showed promising results to detect early right ventricle abnormalities in other settings such as pulmonary hypertension or scleroderma. We therefore decided to determine whether 2D strain could help detect early right ventricular dysfunction in ARDS.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2013
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 4, 2012
CompletedFirst Posted
Study publicly available on registry
December 31, 2012
CompletedStudy Start
First participant enrolled
January 3, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 17, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
October 25, 2017
CompletedNovember 8, 2022
May 1, 2022
2.2 years
December 4, 2012
November 7, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Right ventricle 2D strain
We will assess whether 2D strain can detect a right ventricular dysfunction as compared to standard echocardiographic parameters
Duration of mechanical ventilation
Secondary Outcomes (3)
Mean right ventricle strain under ventilated patients
at inclusion
Reproducibility between transthoracic and transesophageal strain measures
Time of mechanical ventilation
NT pro BNP and pre pro endothelin plasma level
At inclusion in ARDS patients
Study Arms (3)
ARDS group
Patients under mechanical ventilation since less than 24 hours at inclusion and presenting acute respiratory distress syndrome criteria.
ALI group
Patients under mechanical ventilation and presenting acute lung injury criteria.
Control Group
Patients under mechanical ventilation for a non-respiratory cause
Eligibility Criteria
Patients are recruited in our medical intensive care unit at Grenoble University Hospital.
You may qualify if:
- Need for mechanical ventilation
- ARDS criteria met: Respiratory failure not fully explained by cardiac failure, Pao2/FiO2\<200, bilateral opacities on Chest imaging, all symptoms appeared within 1 week
You may not qualify if:
- Predictable duration of mechanical ventilation shorter than 48 hours
- Contraindication to transesophageal echocardiography
- ALI group:
- Need for mechanical ventilation
- ALI criteria met: Respiratory failure not fully explained by cardiac failure, Pao2/FiO2\<300, bilateral opacities on Chest imaging, all symptoms appeared within 1 week
- Predictable duration of mechanical ventilation shorter than 48 hours
- Control Group:
- Need for mechanical ventilation for a non-respiratory cause
- Need for FiO2\>30%
- Known cardiac abnormalities
- Cardiac drugs intake during last 24 hours
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital of Grenoble
Grenoble, Cedex 09, 38043, France
Biospecimen
Plasmatic levels of NT proBNP and pre pro endothelin are monitored in ARDS group to determine whether these biomarkers can help detect right ventricular dysfunction.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Carole SCHWEBEL, PU/PH
University Hospital, Grenoble
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 4, 2012
First Posted
December 31, 2012
Study Start
January 3, 2013
Primary Completion
March 17, 2015
Study Completion
October 25, 2017
Last Updated
November 8, 2022
Record last verified: 2022-05